10 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
anticoagulation #clotting #INR ... #heparin #LMWH ... #NOAC #warfarin ... #coumadin #rivaroxaban ... #Pradaxa #management
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
conformational changes in ... - Rivaroxaban ... #LMWH #UFH #DOAC ... #Dabigatran #Apixaban ... #NOAC #Mechanism
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... inhibitors - Apixaban, rivaroxaban ... ) inhibitors - Dabigatran ... comparison #table #management
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... , edoxaban and rivaroxaban ... anticoagulant; LMWH ... molecular weight heparin ... Anticoagulation #Management
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
initiated after a LMWH ... ¥LMWH is currently ... anticoagulant; LMWH ... low-molecular-weight heparin ... Anticoagulation #Management
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
thrombin inhibitor (dabigatran ... Xa inhibitors (rivaroxaban ... Warfarin: therapeutic INR ... Fibrillation #AFib #diagnosis ... #management #cardiology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
and Management ... venous (DVT/PE) or arterial ... Management: • ... , Bivalirudin, DOAC ... ↑ thrombosis w/in
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... diagnosis and management ... inferior vena cava, LMWH ... unfractionated heparin ... thromboembolism #diagnosis
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Avoid Warfarin and DOAC ... Serial TTE and close ... Cardiomyopathy #diagnosis ... #management #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... one post op Cardiology ... CARP, DECREASE V trials ... medical and surgical management ... stratification #diagnosis